Showing results (111-120 of 160) with videos related to

Sort By:
Pageof 16
BMC Pregnancy and Childbirth|December 3, 2013
Management of hepatitis B in pregnant women and infants: a multicentre audit from four London hospitalsGauri Godbole, Dianne Irish, Marina Basarab, et al.
Plant Biotechnology Journal|February 26, 2026
Systemic Delivery of Functional Proteins Into Plants Using an Engineered Membrane Translocation DomainJiyang Wang, Preeti Patel, Prabhat Bhat, et al.
Journal of Virology|December 13, 2003
Tetracycline-inducible packaging cell line for production of flavivirus replicon particlesTracey J Harvey, Wen Jun Liu, Xiang Ju Wang, et al.
Antiviral Research|June 6, 2013
Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replicationKoen W R van Cleef, Gijs J Overheul, Michael C Thomassen, et al.
Journal of Cardiac Surgery|October 8, 2020
Management of acute and chronic aortic disease during the COVID-19 pandemic-Results from a web-based ad hoc platformMartin Czerny, Jos van den Berg, Roberto Chiesa, et al.
Gastroenterology|July 14, 2009
Temporal analysis of early immune responses in patients with acute hepatitis B virus infectionClaire Dunn, Dimitra Peppa, Pooja Khanna, et al.
Antimicrobial Agents and Chemotherapy|September 15, 2010
A derivate of the antibiotic doxorubicin is a selective inhibitor of dengue and yellow fever virus replication in vitroSuzanne J F Kaptein, Tine De Burghgraeve, Mathy Froeyen, et al.
Plos One|May 25, 2012
An analogue of the antibiotic teicoplanin prevents flavivirus entry in vitroTine De Burghgraeve, Suzanne J F Kaptein, Nilda V Ayala-Nunez, et al.
Pageof 16